ArticleCureus2026
Widely Invasive Follicular Thyroid Carcinoma With Extensive Nodal Metastases and Subsequent Atypical Locoregional Recurrences: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Follicular thyroid carcinoma (FTC) is a well-recognized thyroid malignancy classically known for hematogenous spread, making extensive lymph node involvement at diagnosis an atypical finding. Here, we present the case of a 49-year-old man with widely invasive FTC presenting with an extraordinary burden of metastatic cervical lymph nodes at diagnosis. He subsequently developed two sequential locoregional recurrences at atypical locations, the retropharyngeal space and the superior mediastinum, and ultimately achieved no evidence of disease. This case highlights the potential for widely invasive FTC to present with an extraordinary nodal burden and to recur at unusual anatomic locations not typically associated with FTC. It also demonstrates that meaningful disease control was achieved in this case despite aggressive disease features, provided recurrences are detected early and managed promptly with a multidisciplinary approach. Clinicians should maintain a low threshold for biopsy of new findings on surveillance imaging in patients with a history of widely invasive FTC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.